Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of tazarotene gel 0.1% for mild to moderate nail psoriasis
2013-004519-28Phase 2Completed
- Sponsor
- Almirall
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in nail psoriasis comparing Tazarotene gel 0.1% with Vehicle gel (2 arms). Primary endpoint: Percent change from baseline in mNAPSI of the target fingernail at Day 85. Started Nov 2013; status: completed.
02
Drugs
tazarotene
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on 2013-004519-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004519-28.